{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:22:17Z","timestamp":1752283337243},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,6,18]],"date-time":"2011-06-18T00:00:00Z","timestamp":1308355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00105-010-2111-8","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T18:23:01Z","timestamp":1308334981000},"page":"509-515","source":"Crossref","is-referenced-by-count":3,"title":["Kalziphylaxie"],"prefix":"10.1007","volume":"62","author":[{"given":"N.-P.","family":"Hoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Homey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,18]]},"reference":[{"key":"2111_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000166536","volume":"1","author":"Adrogu\u00e9","year":"1981","unstructured":"Adrogu\u00e9 HJ, Frazier MR, Zeluff B, Suki WN (1981) Systemic calciphylaxis revisited. Am J Nephrol 1:177\u2013183","journal-title":"Am J Nephrol"},{"key":"2111_CR2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/01.gme.0000184422.50696.ef","volume":"12","author":"Bakhireva","year":"2005","unstructured":"Bakhireva LN, Barrett-Connor EL, Laughlin GA, Kritz-Silverstein D (2005) Differences in association of bone mineral density with coronary artery calcification in men and women: the Rancho Bernardo Study. Menopause 12:691\u2013698","journal-title":"Menopause"},{"key":"2111_CR3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR et al (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260\u20131268","journal-title":"Genes Dev"},{"key":"2111_CR4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1681\/ASN.V77978","volume":"7","author":"Budisavljevic","year":"1996","unstructured":"Budisavljevic MN, Cheek D, Ploth DW (1996) Calciphylaxis in chronic renal failure. J Am Soc Nephrol 7:978\u2013982","journal-title":"J Am Soc Nephrol"},{"key":"2111_CR5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1159\/000088809","volume":"25","author":"Brancaccio","year":"2005","unstructured":"Brancaccio D, Biondi ML, Gallieni M et al (2005) Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol 25:548\u2013552","journal-title":"Am J Nephrol"},{"key":"2111_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2133.1983.tb03996.x","volume":"109","author":"Chan","year":"1983","unstructured":"Chan YL, Mahony JF, Turner JJ, Posen S (1983) The vascular lesions associated with skin necrosis in renal disease. Br J Dermatol 109:85\u201395","journal-title":"Br J Dermatol"},{"key":"2111_CR7","first-page":"648","volume":"23","author":"Cozzolino","year":"2010","unstructured":"Cozzolino M, Brandenburg V (2010) Warfarin: to use or not to use in chronic kidney disease patients? J Nephrol 23:648\u2013652","journal-title":"J Nephrol"},{"key":"2111_CR8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0272-6386(95)90116-7","volume":"25","author":"Fine","year":"1995","unstructured":"Fine A, Fleming S, Leslie W (1995) Calciphylaxis presenting with calf pain and plaques in four continuous ambulatory peritoneal dialysis patients and in one predialysis patient. Am J Kidney Dis 25:498\u2013502","journal-title":"Am J Kidney Dis"},{"key":"2111_CR9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","volume":"361","author":"Ketteler","year":"2003","unstructured":"Ketteler M, Bongartz P, Westenfeld R et al (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827\u2013833","journal-title":"Lancet"},{"key":"2111_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.1840130211","volume":"13","author":"Khoruts","year":"1991","unstructured":"Khoruts A, Stahnke L, McClain CJ et al (1991) Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267\u2013276","journal-title":"Hepatology"},{"key":"2111_CR11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/003693300404900313","volume":"49","author":"Lang","year":"2004","unstructured":"Lang N, Davie R, Whitworth C (2004) Fatal calcific uraemic arteriolopathy (CUA): a case report and review of the literature. Scott Med J 49:108\u2013111","journal-title":"Scott Med J"},{"key":"2111_CR12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.surg.2009.09.022","volume":"146","author":"Lal","year":"2009","unstructured":"Lal G, Nowell AG, Liao J et al (2009) Determinants of survival in patients with calciphylaxis: a multivariate analysis. Surgery 146:1028\u20131034","journal-title":"Surgery"},{"key":"2111_CR13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"London","year":"2004","unstructured":"London GM, Marty C, Marchais SJ et al (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943\u20131951","journal-title":"J Am Soc Nephrol"},{"key":"2111_CR14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/00007611-199611000-00016","volume":"89","author":"Lue","year":"1996","unstructured":"Lue C, Boulware DW, Sanders PW et al (1996) Calciphylaxis mimicking skin lesions of connective tissue diseases. South Med J 89:1099\u20131100","journal-title":"South Med J"},{"key":"2111_CR15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9343(90)90150-C","volume":"88","author":"Mehta","year":"1990","unstructured":"Mehta RL, Scott G, Sloand JA, Francis CW (1990) Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis. Am J Med 88:252\u2013257","journal-title":"Am J Med"},{"key":"2111_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ndt\/gfm676","volume":"23","author":"Mohammed","year":"2008","unstructured":"Mohammed IA, Sekar V, Bubtana AJ et al (2008) Proximal calciphylaxis treated with calcimimetic \u201eCinacalcet\u201c. Nephrol Dial Transplant 23:387\u2013389","journal-title":"Nephrol Dial Transplant"},{"key":"2111_CR17","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/ndt\/gfh305","volume":"19","author":"Monney","year":"2004","unstructured":"Monney P, Nguyen QV, Perroud H, Descombes E (2004) Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 19:2130\u20132132","journal-title":"Nephrol Dial Transplant"},{"key":"2111_CR18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1046\/j.1523-1755.1998.00088.x","volume":"54","author":"Nordfors","year":"1998","unstructured":"Nordfors L, L\u00f6nnqvist F, Heimb\u00fcrger O et al (1998) Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 54:1267\u20131275","journal-title":"Kidney Int"},{"key":"2111_CR19","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/16.11.2176","volume":"16","author":"Podymow","year":"2001","unstructured":"Podymow T, Wherrett C, Burns KD (2001) Hyperbaric oxygen in the treatment of calciphylaxis: a case series. Nephrol Dial Transplant 16:2176\u20132180","journal-title":"Nephrol Dial Transplant"},{"key":"2111_CR20","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","volume":"15","author":"Reynolds","year":"2004","unstructured":"Reynolds JL, Joannides AJ, Skepper JN et al (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857\u20132867","journal-title":"J Am Soc Nephrol"},{"key":"2111_CR21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/ajkd.1998.v32.pm9740168","volume":"32","author":"Sankarasubbaiyan","year":"1998","unstructured":"Sankarasubbaiyan S, Scott G, Holley JL (1998) Cryofibrinogenemia: an addition to the differential diagnosis of calciphylaxis in end-stage renal disease. Am J Kidney Dis 32:494\u2013498","journal-title":"Am J Kidney Dis"},{"key":"2111_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2009.99","volume":"5","author":"Schlieper","year":"2009","unstructured":"Schlieper G, Brandenburg V, Ketteler M, Floege J (2009) Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 5:539\u2013543","journal-title":"Nat Rev Nephrol"},{"key":"2111_CR23","unstructured":"Selye H (1962) Calciphlaxis. University of Chicago Press, Chicago, S 1"},{"key":"2111_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.ajkd.2006.04.062","volume":"48","author":"Shiraishi","year":"2006","unstructured":"Shiraishi N, Kitamura K, Miyoshi T et al (2006) Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis 48:151\u2013154","journal-title":"Am J Kidney Dis"},{"key":"2111_CR25","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/01.CIR.102.21.2636","volume":"102","author":"Tintut","year":"2000","unstructured":"Tintut Y, Patel J, Parhami F, Demer LL (2000) Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636\u20132642","journal-title":"Circulation"},{"key":"2111_CR26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630152696035","volume":"12","author":"Tittelbach","year":"2001","unstructured":"Tittelbach J, Graefe T, Wollina U (2001) Painful ulcers in calciphylaxis \u2013 combined treatment with maggot therapy and oral pentoxyfillin. J Dermatol Treat 12:211\u2013214","journal-title":"J Dermatol Treat"},{"key":"2111_CR27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.ajkd.2009.03.015","volume":"55","author":"Vargemezis","year":"2010","unstructured":"Vargemezis V, Liakopoulos V, Kriki P et al (2010) Pivotal role of paricalcitol in the treatment of calcific uremic arteriolopathy in the presence of a parathyroid adenoma. Am J Kidney Dis 55:144\u2013147","journal-title":"Am J Kidney Dis"},{"key":"2111_CR28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2006.08.065","volume":"56","author":"Weenig","year":"2007","unstructured":"Weenig RH, Hewell LD, Davis MD et al (2007) Calciphlaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56:569\u2013579","journal-title":"J Am Acad Dermatol"},{"key":"2111_CR29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaad.2007.12.006","volume":"58","author":"Weenig","year":"2008","unstructured":"Weenig RH (2008) Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol 58:458\u2013471","journal-title":"J Am Acad Dermatol"},{"key":"2111_CR30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00105-010-2026-4","volume":"61","author":"Wollina","year":"2010","unstructured":"Wollina U (2010) Cutaneous calciphylaxis. Hautarzt 61:1063\u20131071","journal-title":"Hautarzt"},{"key":"2111_CR31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcb.10669","volume":"90","author":"Zebboudj","year":"2003","unstructured":"Zebboudj AF, Shin V, Bostr\u00f6m K (2003) Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90:756\u2013765","journal-title":"J Cell Biochem"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2111-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-010-2111-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2111-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T11:32:08Z","timestamp":1637839928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-010-2111-8"}},"subtitle":["Pathogenese und Therapie"],"short-title":[],"issued":{"date-parts":[[2011,6,18]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["2111"],"URL":"https:\/\/doi.org\/10.1007\/s00105-010-2111-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,18]]}}}